학술논문
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
Document Type
Article
Author
Kandolf Sekulovic, L.; Peris, K.; Hauschild, A.; Stratigos, A.; Grob, J.-J.; Nathan, P.; Dummer, R.; Forsea, A.-M.; Hoeller, C.; Gogas, H.; Demidov, L.; Lebbe, C.; Blank, C.; Olah, J.; Bastholt, L.; Herceg, D.; Neyns, B.; Vieira, R.; Hansson, J.; Rutkowski, P.; Krajsova, I.; Bylaite-Bucinskiene, M.; Zalaudek, I.; Maric-Brozic, J.; Babovic, N.; Banjin, M.; Putnik, K.; Weinlich, G.; Todorovic, V.; Kirov, K.; Ocvirk, J.; Zhukavets, A.; Kukushkina, M.; De La Cruz Merino, L.; Ymeri, A.; Risteski, M.; Garbe, C.
Source
In European Journal of Cancer April 2017 75:313-322
Subject
Language
ISSN
0959-8049